Haemonetics (HAE)
(Delayed Data from NYSE)
$84.13 USD
+1.07 (1.29%)
Updated Jul 3, 2024 01:00 PM ET
After-Market: $84.13 0.00 (0.00%) 7:58 PM ET
1-Strong Buy of 5 1
B Value C Growth C Momentum B VGM
Industry / Sector Report
Industry : Medical - Products
Zacks Industry Rank
Bottom 40% (150 out of 249)Zacks Sector Rank
Top 31% (5 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.67 | 1.69 | 9.99 |
Current Quarter Estimate | 1.03 | 5.88 | 61.00 |
Year Ago Quarter Estimate | 1.05 | 4.88 | 54.84 |
Next Quarter Estimate | 1.11 | 7.06 | 63.00 |
Next Year Estimate | 5.12 | 39.92 | 270.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 15.40 | 12.90 | 15.67 |
Next Year | 12.04 | 25.80 | 9.31 |
Last 5 Years | 9.40 | 3.90 | 8.10 |
Next 5 Years | 12.00 | 13.40 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | 21.14 | -13.85 |
Price/Book (MRQ) | 4.45 | 2.02 |
Price/Cash Flow (MRFY) | 13.90 | 10.96 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | 8.98% | -7.07% |
Return on Equity (TTM) | 22.25% | 6.21% |
Debt to Equity (MRQ) | NA | 17.49 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.